EDUCATION

Medical School

  • University of Maryland School of Medicine , 1980 , Baltimore , MD

Internship

  • Children's Hospital of Philadelphia , 1981 , Philadelphia , PA

Residency

Radiation Therapy
  • Harvard Joint Center for Radiation Therapy , 1989 , Boston , MA

Fellowship

Radiation Therapy
  • National Cancer Institute , 1986 , Bethesda , MD

CERTIFICATIONS

  • American Board of Medical Specialties, Pediatric Therapeutic Radiology

PUBLICATIONS

Publications powered by Harvard Catalyst Profiles

  1. Outcomes after first relapse of childhood intracranial ependymoma. Pediatr Blood Cancer. 2021 Feb 09; e28930. View abstract
  2. A Multi-institutional Comparative Analysis of Proton and Photon Therapy-Induced Hematologic Toxicity in Patients With Medulloblastoma. Int J Radiat Oncol Biol Phys. 2021 Mar 01; 109(3):726-735. View abstract
  3. Introduction to the COG/SIOP/PROS supplement on radiation oncology. Pediatr Blood Cancer. 2020 Oct 21; e28768. View abstract
  4. Postoperative MR imaging surveillance of pediatric craniopharyngioma: new institutional guidelines. Childs Nerv Syst. 2021 Mar; 37(3):853-861. View abstract
  5. Phase I/II Study of Stereotactic Body Radiation Therapy for Pulmonary Metastases in Pediatric Patients. Adv Radiat Oncol. 2020 Nov-Dec; 5(6):1267-1273. View abstract
  6. Novel predictive scoring system for morbid hypothalamic obesity in patients with pediatric craniopharyngioma. Childs Nerv Syst. 2021 Feb; 37(2):403-410. View abstract
  7. Training and education of pediatric radiation oncologists: A survey from the 2019 Pediatric Radiation Oncology Society meeting. Pediatr Blood Cancer. 2020 10; 67(10):e28619. View abstract
  8. Practice patterns and recommendations for pediatric image-guided radiotherapy: A Children's Oncology Group report. Pediatr Blood Cancer. 2020 10; 67(10):e28629. View abstract
  9. Role of Surgery in Rhabdomyosarcoma of the Head and Neck in Children. Laryngoscope. 2021 03; 131(3):E984-E992. View abstract
  10. The use of interval-compressed chemotherapy with the addition of vincristine, irinotecan, and temozolomide for pediatric patients with newly diagnosed desmoplastic small round cell tumor. Pediatr Blood Cancer. 2020 10; 67(10):e28559. View abstract
  11. The COVID-19 pandemic: A rapid global response for children with cancer from SIOP, COG, SIOP-E, SIOP-PODC, IPSO, PROS, CCI, and St Jude Global. Pediatr Blood Cancer. 2020 07; 67(7):e28409. View abstract
  12. Sustainable care for children with cancer: a Lancet Oncology Commission. Lancet Oncol. 2020 04; 21(4):e185-e224. View abstract
  13. Palliative radiotherapy for pediatric patients: Parental perceptions of indication, intent, and outcomes. Pediatr Blood Cancer. 2020 01; 67(1):e28003. View abstract
  14. Revisiting the Role of Radiation Therapy for Pediatric Low-Grade Glioma. J Clin Oncol. 2019 12 10; 37(35):3335-3339. View abstract
  15. Brainstem Injury in Pediatric Patients Receiving Posterior Fossa Photon Radiation. Int J Radiat Oncol Biol Phys. 2019 12 01; 105(5):1034-1042. View abstract
  16. Assembling the brain trust: the multidisciplinary imperative in neuro-oncology. Nat Rev Clin Oncol. 2019 08; 16(8):521-522. View abstract
  17. Sixty years single institutional experience with pediatric craniopharyngioma: between the past and the future. Childs Nerv Syst. 2020 02; 36(2):291-296. View abstract
  18. Clinical Impact of Tumor Mutational Burden in Neuroblastoma. J Natl Cancer Inst. 2019 07 01; 111(7):695-699. View abstract
  19. In Memoriam: Giulio D'Angio, MD, May 2, 1922-September 14, 2018. Int J Radiat Oncol Biol Phys. 2019 Jul 01; 104(3):478-480. View abstract
  20. Radiation Prophylaxis for Hip Salvage Surgery in Cerebral Palsy: Can We Reduce the Incidence of Heterotopic Ossification? J Pediatr Orthop. 2019 May/Jun; 39(5):e386-e391. View abstract
  21. Phase I study of gene-mediated cytotoxic immunotherapy with AdV-tk as adjuvant to surgery and radiation for pediatric malignant glioma and recurrent ependymoma. Neuro Oncol. 2019 03 18; 21(4):537-546. View abstract
  22. Moody D. Wharam Jr, MD, FACR, FASTRO, July 22, 1941-August 10, 2018. Int J Radiat Oncol Biol Phys. 2019 Apr 01; 103(5):1026-1030. View abstract
  23. Mucoepidermoid carcinoma of the head and neck in children. Int J Pediatr Otorhinolaryngol. 2019 May; 120:93-99. View abstract
  24. Larry Emanuel Kun, March 10, 1946-May 27, 2018. Int J Radiat Oncol Biol Phys. 2019 Jan 01; 103(1):8-14. View abstract
  25. Cardiac-Sparing Whole Lung IMRT in Patients With Pediatric Tumors and Lung Metastasis: Final Report of a Prospective Multicenter Clinical Trial. Int J Radiat Oncol Biol Phys. 2019 01 01; 103(1):28-37. View abstract
  26. Excellent Outcomes Following Response-based Omission of Radiotherapy in Children and Adolescents With Intermediate or High-risk Hodgkin Lymphoma. J Pediatr Hematol Oncol. 2018 08; 40(6):e338-e342. View abstract
  27. The Children's Oncology Group Radiation Oncology Discipline: 15 Years of Contributions to the Treatment of Childhood Cancer. Int J Radiat Oncol Biol Phys. 2018 07 15; 101(4):860-874. View abstract
  28. Pediatric NUT-midline carcinoma: Therapeutic success employing a sarcoma based multimodal approach. Pediatr Hematol Oncol. 2017 May; 34(4):231-237. View abstract
  29. Reduced Mortality Risk in the Recent Era in Early-Stage Hodgkin Lymphoma Patients Treated With Radiation Therapy With or Without Chemotherapy. Int J Radiat Oncol Biol Phys. 2018 02 01; 100(2):498-506. View abstract
  30. Clinical outcomes and toxicity following palliative radiotherapy for childhood cancers. Pediatr Blood Cancer. 2018 Jan; 65(1). View abstract
  31. Identification of Patients With Localized Ewing Sarcoma at Higher Risk for Local Failure: A Report From the Children's Oncology Group. Int J Radiat Oncol Biol Phys. 2017 12 01; 99(5):1286-1294. View abstract
  32. Rethinking childhood ependymoma: a retrospective, multi-center analysis reveals poor long-term overall survival. J Neurooncol. 2017 Oct; 135(1):201-211. View abstract
  33. Localized Adult Ewing Sarcoma: Favorable Outcomes with Alternating Vincristine, Doxorubicin, Cyclophosphamide, and Ifosfamide, Etoposide (VDC/IE)-Based Multimodality Therapy. Oncologist. 2017 10; 22(10):1265-1270. View abstract
  34. Delivery of radiation therapy in resource-limited settings: A pilot quality assessment study. Pediatr Blood Cancer. 2017 Aug; 64(8). View abstract
  35. Patterns of Relapse in High-Risk Neuroblastoma Patients Treated With and Without Total Body Irradiation. Int J Radiat Oncol Biol Phys. 2017 02 01; 97(2):270-277. View abstract
  36. Central Versus Extraventricular Neurocytoma in Children: A Clinicopathologic Comparison and Review of the Literature. J Pediatr Hematol Oncol. 2016 08; 38(6):479-85. View abstract
  37. Local Control Modality and Outcome for Ewing Sarcoma of the Femur: A Report From the Children's Oncology Group. Ann Surg Oncol. 2016 10; 23(11):3541-3547. View abstract
  38. Proton beam therapy for medulloblastoma - Author's reply. Lancet Oncol. 2016 05; 17(5):e174-5. View abstract
  39. Paediatric radiation oncology in the care of childhood cancer: A position paper by the International Paediatric Radiation Oncology Society (PROS). Radiother Oncol. 2016 05; 119(2):357-60. View abstract
  40. Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study. Lancet Oncol. 2016 Mar; 17(3):287-298. View abstract
  41. Myxopapillary ependymomas in children: imaging, treatment and outcomes. J Neurooncol. 2016 Jan; 126(1):165-174. View abstract
  42. Use and Effectiveness of Gonadotropin-Releasing Hormone Agonists for Prophylactic Menstrual Suppression in Postmenarchal Women Who Undergo Hematopoietic Cell Transplantation. J Pediatr Adolesc Gynecol. 2016 Jun; 29(3):265-8. View abstract
  43. Age, Tumor Characteristics, and Treatment Regimen as Event Predictors in Ewing: A Children's Oncology Group Report. Sarcoma. 2015; 2015:927123. View abstract
  44. Medical and Psychosocial Correlates of Insomnia Symptoms in Adult Survivors of Pediatric Brain Tumors. J Pediatr Psychol. 2016 Jul; 41(6):623-30. View abstract
  45. Whole Lung Irradiation in Adults with Metastatic Ewing Sarcoma: Practice Patterns and Implications for Treatment. Sarcoma. 2015; 2015:591698. View abstract
  46. Proton therapy for pediatric and adolescent esthesioneuroblastoma. Pediatr Blood Cancer. 2015 Sep; 62(9):1523-8. View abstract
  47. Preliminary results of a phase II trial of proton radiotherapy for pediatric rhabdomyosarcoma. J Clin Oncol. 2014 Nov 20; 32(33):3762-70. View abstract
  48. Comparative evaluation of local control strategies in localized Ewing sarcoma of bone: a report from the Children's Oncology Group. Cancer. 2015 Feb 01; 121(3):467-75. View abstract
  49. Clinical outcomes and late endocrine, neurocognitive, and visual profiles of proton radiation for pediatric low-grade gliomas. Int J Radiat Oncol Biol Phys. 2014 Aug 01; 89(5):1060-1068. View abstract
  50. SU-E-T-127: Dosimetric Evaluation Microbeam Treatment Method Using Monoenergetic Photon Î1/4-Beams. Med Phys. 2014 Jun; 41(6):251. View abstract
  51. Likelihood of bone recurrence in prior sites of metastasis in patients with high-risk neuroblastoma. Int J Radiat Oncol Biol Phys. 2014 Jul 15; 89(4):839-45. View abstract
  52. Braching news about rhabdomyosarcoma. Pediatr Blood Cancer. 2014 Jul; 61(7):1151. View abstract
  53. Thyroid malignancies in survivors of Hodgkin lymphoma. Int J Radiat Oncol Biol Phys. 2014 Mar 01; 88(3):636-41. View abstract
  54. Blood pressure is associated with occult cardiovascular disease in prospectively studied Hodgkin lymphoma survivors after chest radiation. Leuk Lymphoma. 2014 Nov; 55(11):2477-83. View abstract
  55. Low-Z linac targets for low-MV gold nanoparticle radiation therapy. Med Phys. 2014 Feb; 41(2):021701. View abstract
  56. Long-term outcome of 4,040 children diagnosed with pediatric low-grade gliomas: an analysis of the Surveillance Epidemiology and End Results (SEER) database. Pediatr Blood Cancer. 2014 Jul; 61(7):1173-9. View abstract
  57. Proton radiotherapy for pediatric central nervous system ependymoma: clinical outcomes for 70 patients. Neuro Oncol. 2013 Nov; 15(11):1552-9. View abstract
  58. Second nonocular tumors among survivors of retinoblastoma treated with contemporary photon and proton radiotherapy. Cancer. 2014 Jan 01; 120(1):126-33. View abstract
  59. Relapse after treatment of pediatric Hodgkin lymphoma: outcome and role of surveillance after end of therapy. Pediatr Blood Cancer. 2013 Sep; 60(9):1458-63. View abstract
  60. The presentation and management of mandibular tumors in the pediatric population. Laryngoscope. 2013 Aug; 123(8):2035-42. View abstract
  61. Prospective study of the efficacy of breast magnetic resonance imaging and mammographic screening in survivors of Hodgkin lymphoma. J Clin Oncol. 2013 Jun 20; 31(18):2282-8. View abstract
  62. Beam quality and dose perturbation of 6 MV flattening-filter-free linac. Phys Med. 2014 Feb; 30(1):47-56. View abstract
  63. Locoregional recurrence after preoperative radiation therapy for retroperitoneal sarcoma: adverse impact of multifocal disease and potential implications of dose escalation. Ann Surg Oncol. 2013 Jul; 20(7):2140-7. View abstract
  64. Impact of beam quality on megavoltage radiotherapy treatment techniques utilizing gold nanoparticles for dose enhancement. Phys Med Biol. 2013 Feb 07; 58(3):451-64. View abstract
  65. Predictors for major wound complications following preoperative radiotherapy and surgery for soft-tissue sarcoma of the extremities and trunk: importance of tumor proximity to skin surface. Ann Surg Oncol. 2013 May; 20(5):1494-9. View abstract
  66. Myocardial 2D strain echocardiography and cardiac biomarkers in children during and shortly after anthracycline therapy for acute lymphoblastic leukaemia (ALL): a prospective study. Eur Heart J Cardiovasc Imaging. 2013 Jun; 14(6):562-9. View abstract
  67. Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group. J Clin Oncol. 2012 Nov 20; 30(33):4148-54. View abstract
  68. Association between radiotherapy vs no radiotherapy based on early response to VAMP chemotherapy and survival among children with favorable-risk Hodgkin lymphoma. JAMA. 2012 Jun 27; 307(24):2609-16. View abstract
  69. Phase II trial of trastuzumab in combination with cytotoxic chemotherapy for treatment of metastatic osteosarcoma with human epidermal growth factor receptor 2 overexpression: a report from the children's oncology group. J Clin Oncol. 2012 Jul 10; 30(20):2545-51. View abstract
  70. Sleep dysfunction in long term survivors of craniopharyngioma. J Neurooncol. 2012 Jul; 108(3):543-9. View abstract
  71. Lung malignancies after Hodgkin lymphoma: disease characteristics, detection methods and clinical outcome. Ann Oncol. 2012 Jul; 23(7):1813-8. View abstract
  72. Adverse outcome analyses of observational data: assessing cardiovascular risk in HIV disease. Clin Infect Dis. 2012 Feb 01; 54(3):408-13. View abstract
  73. Proton radiotherapy for pediatric Ewing's sarcoma: initial clinical outcomes. Int J Radiat Oncol Biol Phys. 2012 Mar 01; 82(3):1142-8. View abstract
  74. A modification of flattening filter free linac for IMRT. Med Phys. 2011 May; 38(5):2342-52. View abstract
  75. Combining magnetic resonance spectroscopy and molecular genomics offers better accuracy in brain tumor typing and prediction of survival than either methodology alone. Int J Oncol. 2011 Apr; 38(4):1113-27. View abstract
  76. Linear accelerator-based stereotactic radiosurgery for brainstem metastases: the Dana-Farber/Brigham and Women's Cancer Center experience. J Neurooncol. 2011 Sep; 104(2):553-7. View abstract
  77. Stereotactic irradiation of the postoperative resection cavity for brain metastasis: a frameless linear accelerator-based case series and review of the technique. Int J Radiat Oncol Biol Phys. 2012 Jan 01; 82(1):95-101. View abstract
  78. Long-term clinical outcomes following treatment of childhood craniopharyngioma. Pediatr Blood Cancer. 2011 Jul 01; 56(7):1120-6. View abstract
  79. Factors predicting local recurrence, metastasis, and survival in pediatric soft tissue sarcoma in extremities. Clin Orthop Relat Res. 2010 Nov; 468(11):3019-27. View abstract
  80. Clinically significant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation. Blood. 2011 Jan 13; 117(2):412-8. View abstract
  81. Association of rapidly progressive moyamoya syndrome with bevacizumab treatment for glioblastoma in a child with neurofibromatosis type 1. J Child Neurol. 2011 Feb; 26(2):228-30. View abstract
  82. Germinoma with malignant transformation to nongerminomatous germ cell tumor. J Neurosurg Pediatr. 2010 Sep; 6(3):295-8. View abstract
  83. ACR Appropriateness Criteria: single brain metastasis. Curr Probl Cancer. 2010 May-Jun; 34(3):162-74. View abstract
  84. Head and neck carcinomas across the age spectrum: epidemiology, therapy, and late effects. Semin Radiat Oncol. 2010 Jan; 20(1):52-7. View abstract
  85. American College of Radiology appropriateness criteria on multiple brain metastases. Int J Radiat Oncol Biol Phys. 2009 Nov 15; 75(4):961-5. View abstract
  86. Sinonasal and laryngeal carcinoma in children: correlation of imaging characteristics with clinicopathologic and cytogenetic features. AJNR Am J Neuroradiol. 2010 Feb; 31(2):257-61. View abstract
  87. A prospective, blinded analysis of A-PROTEIN (recoverin or CAR protein) levels in pediatric patients with central nervous system tumors. Pediatr Blood Cancer. 2009 Sep; 53(3):343-7. View abstract
  88. Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children's Oncology Group Study. J Clin Oncol. 2009 May 20; 27(15):2536-41. View abstract
  89. Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor. J Clin Oncol. 2009 Jan 20; 27(3):385-9. View abstract
  90. Hepatoblastoma presenting with focal nodular hyperplasia after treatment of neuroblastoma. J Pediatr Surg. 2008 Dec; 43(12):2297-300. View abstract
  91. Unilateral and bilateral breast cancer in women surviving pediatric Hodgkin's disease. Int J Radiat Oncol Biol Phys. 2008 Sep 01; 72(1):34-40. View abstract
  92. Outcome of pediatric pineoblastoma after surgery, radiation and chemotherapy. J Neurooncol. 2008 Aug; 89(1):89-95. View abstract
  93. Laparoscopic oophoropexy prior to radiation for pediatric brain tumor and subsequent ovarian function. Hum Reprod. 2008 Jan; 23(1):117-21. View abstract
  94. Changes in cerebral cortex of children treated for medulloblastoma. Int J Radiat Oncol Biol Phys. 2007 Jul 15; 68(4):992-8. View abstract
  95. Moyamoya following cranial irradiation for primary brain tumors in children. Neurology. 2007 Mar 20; 68(12):932-8. View abstract
  96. Predicting survival of children with CNS tumors using proton magnetic resonance spectroscopic imaging biomarkers. Int J Oncol. 2007 Mar; 30(3):651-7. View abstract
  97. Extracranial metastases of glioblastoma in a child: case report and review of the literature. J Pediatr Hematol Oncol. 2007 Mar; 29(3):190-4. View abstract
  98. Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease. J Clin Oncol. 2007 Jan 20; 25(3):332-7. View abstract
  99. Phase II study of thalidomide and radiation in children with newly diagnosed brain stem gliomas and glioblastoma multiforme. J Neurooncol. 2007 Mar; 82(1):95-101. View abstract
  100. Transverse myelitis after therapy for primitive neuroectodermal tumors. Pediatr Neurol. 2006 Aug; 35(2):122-5. View abstract
  101. Atypical teratoid/rhabdoid tumor: the controversy behind radiation therapy. J Neurooncol. 2007 Jan; 81(1):97-111. View abstract
  102. Intracranial germinomas: can we improve upon our success? Pediatr Blood Cancer. 2006 Jul; 47(1):2-3. View abstract
  103. High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: long-term survival update. J Clin Oncol. 2006 Jun 20; 24(18):2891-6. View abstract
  104. Mucoepidermoid carcinoma of the parotid gland in children: A 10-year experience. Arch Otolaryngol Head Neck Surg. 2006 Apr; 132(4):375-80. View abstract
  105. High Risk Neuroblastoma Treated with Tandem Autologous Peripheral Blood Stem Cell-Supported Transplant: Long-term Survival Update. Journal of Clinical Oncology. 2006; 24:2891-2896. View abstract
  106. Tumor cell-associated neuropilin-1 and vascular endothelial growth factor expression as determinants of tumor growth in neuroblastoma. Neuropathology. 2005 Sep; 25(3):178-87. View abstract
  107. Craniopharyngioma. 2005. View abstract
  108. Aggressive surgical therapy and radiotherapy for patients with high-risk neuroblastoma treated with rapid sequence tandem transplant. J Pediatr Surg. 2005 Jun; 40(6):936-41; discussion 941. View abstract
  109. Continuous remission of newly diagnosed and relapsed central nervous system atypical teratoid/rhabdoid tumor. J Neurooncol. 2005 Mar; 72(1):77-84. View abstract
  110. Stereotactic radiotherapy for localized low-grade gliomas in children: final results of a prospective trial. Int J Radiat Oncol Biol Phys. 2005 Feb 01; 61(2):374-9. View abstract
  111. Continuous Remission of Newly Diagnosed and Relapsed Central Nervous System Atypical Teratoid/Rhabdoid Tumor. International Journal of Radiation Oncology Biology, Physics. 2005; 61:374-379. View abstract
  112. Long-Term Outcomes of Treatment of Pediatric Craniopharyngioma. Society for Neuro-Oncology. 2004. View abstract
  113. Desmoplastic versus non-desmoplastic medulloblastoma: Differences in clinical outcome?. International Symposium of Pediatric Neuro-Oncology. 2004. View abstract
  114. Aggressive surgical and radiotherapy for patients with high risk neuroblastoma treated with rapid sequence tandem transplant. American Academy of Pediatrics, San Francisco. 2004. View abstract
  115. Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease. J Clin Oncol. 2004 Nov 15; 22(22):4541-50. View abstract
  116. Ovarian function in pediatric brain cancer survivors after laparoscopic oophoropexy. Children's Hospital Research Day. 2004. View abstract
  117. Outcome for children with group III rhabdomyosarcoma treated with or without radiotherapy. Int J Radiat Oncol Biol Phys. 2004 Mar 15; 58(4):1208-14. View abstract
  118. Side Effects of Radiotherapy in Children. Supportive Care. 2004. View abstract
  119. Preservation of ovarian function in pediatric brain cancer survivors after laparoscopic oophoropexy. American Society for Reproductive Medicine. 2003. View abstract
  120. Ewing Sarcoma of the Chest Wall: The Impact of Initial Versus Delayed Resection on Tumor Margins, Survival, and Use of Radiation Therapy. American Surgical Association 2003. American Surgical Association. 2003. View abstract
  121. The role of chromosomal translocation (15;19) in the carcinoma of the upper aerodigestive tract in children. Otolaryngol Head Neck Surg. 2003 Dec; 129(6):698-704. View abstract
  122. Primary tumor control in patients with stage 3/4 unfavorable neuroblastoma treated with tandem double autologous stem cell transplants. J Pediatr Hematol Oncol. 2003 Dec; 25(12):934-40. View abstract
  123. Ewing sarcoma/primitive neuroectodermal tumor of the chest wall: impact of initial versus delayed resection on tumor margins, survival, and use of radiation therapy. Ann Surg. 2003 Oct; 238(4):563-7; discussion 567-8. View abstract
  124. Prognostic factors for children with Hodgkin's disease treated with combined-modality therapy. J Clin Oncol. 2003 May 15; 21(10):2026-33. View abstract
  125. Hand-arm vibration syndrome in Swedish car mechanics. Occup Environ Med. 2003 Apr; 60(4):287-94. View abstract
  126. A phase I trial of etanidazole and hyperfractionated radiotherapy in children with diffuse brainstem glioma. Int J Radiat Oncol Biol Phys. 2003 Apr 01; 55(5):1182-5. View abstract
  127. Pediatric Radiation Oncology. 2003. View abstract
  128. Management of Lymphoma in Children. Non-Hodgkin's Lymphoma. 2003. View abstract
  129. Phase II Trial of Thalidomide with radiation in children with brain stem gliomas. ISPNO London. 2002. View abstract
  130. Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors. Blood. 2002 Sep 15; 100(6):1989-96. View abstract
  131. VAMP and low-dose, involved-field radiation for children and adolescents with favorable, early-stage Hodgkin's disease: results of a prospective clinical trial. J Clin Oncol. 2002 Jul 15; 20(14):3081-7. View abstract
  132. Sustained remission after recurrent central nervous system atypical teratoid/rhabdoid tumor: A report of twoo cases. ISPNO London. 2002. View abstract
  133. Neuropsychological Outcomes in Children following Posterior Fossa Syndrome: A report of 4 cases. ISPNO London. 2002. View abstract
  134. Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger. J Clin Oncol. 2002 Apr 15; 20(8):2101-8. View abstract
  135. Effect of total body irradiation dose escalation on outcome following T-cell-depleted allogeneic bone marrow transplantation. Biol Blood Marrow Transplant. 2002; 8(3):139-44. View abstract
  136. Aggressive multimodal treatment of pleuropulmonary blastoma. Ann Thorac Surg. 2001 Sep; 72(3):939-42. View abstract
  137. T-cell--depleted allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma: induction of graft-versus-myeloma effect. Blood. 2001 Aug 15; 98(4):934-9. View abstract
  138. CD6+ donor marrow T-cell depletion as the sole form of graft-versus-host disease prophylaxis in patients undergoing allogeneic bone marrow transplant from unrelated donors. J Clin Oncol. 2001 Feb 15; 19(4):1152-9. View abstract
  139. Pediatric Solid Tumors. Textbook of Clinical Oncology . 2001. View abstract
  140. Comparison of Dose Intensified and Standard Chemotherapy for the Treatment of Ewing's Sarcoma and PNET of Bone and Soft Tissue. SIOP. 2001. View abstract
  141. Prognostic Factors in Pediatric Cancers. Prognostic Factors in Cancer. 2001. View abstract
  142. How are we doing? A statewide survey of community adjustment among people with serious mental illness receiving intensive outpatient services. Community Ment Health J. 2000 Aug; 36(4):363-82. View abstract
  143. Tandem high-dose therapy in rapid sequence for children with high-risk neuroblastoma. J Clin Oncol. 2000 Jul; 18(13):2567-75. View abstract
  144. Survival for patients with peritoneal mesothelioma: A review of aggressive therapy for early stage disease. Presented at the American Society of Clinical Oncology (ASCO). 2000. View abstract
  145. Late events in pediatric patients with Ewing sarcoma/primitive neuroectodermal tumor of bone: the Dana-Farber Cancer Institute/Children's Hospital experience. J Pediatr Hematol Oncol. 1999 Nov-Dec; 21(6):486-93. View abstract
  146. A potential autocrine role for vascular endothelial growth factor (VEGF) in human neuroblastoma (NBL) cells via signaling through the novel VEGF receptor, neuropilin-1. Presented at ASPH/O SIOP Montreal. 1999. View abstract
  147. Adults with Ewing's sarcoma/primitive neuroectodermal tumor: adverse effect of older age and primary extraosseous disease on outcome. Ann Surg. 1999 Jul; 230(1):79-86. View abstract
  148. Low-dose total body irradiation and G-CSF without hematopoietic stem cell support in the treatment of relapsed or refractory acute myelogenous leukemia (AML), or AML in second or subsequent remission. Int J Radiat Oncol Biol Phys. 1998 Dec 01; 42(5):1113-7. View abstract
  149. Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: final report of a randomized, open-labelled, phase II trial. Br J Cancer. 1998 Jun; 77(11):1996-2002. View abstract
  150. Principles of Pediatric Radiation Therapy. Hematological Diseases of Infancy and Childhool. 1998. View abstract
  151. Principles of Radiotherapy. The Lymphomas. 1998. View abstract
  152. Childhood soft tissue sarcoma: a 20-year experience. J Pediatr. 1997 Oct; 131(4):603-7. View abstract
  153. The Changing Role of Radiation Therapy in the Treatment of Neuroblastoma. Semin Radiat Oncol. 1997 Jul; 7(3):195-203. View abstract
  154. CD6-depleted allogeneic bone marrow transplantation for acute leukemia in first complete remission. Blood. 1997 Apr 15; 89(8):3039-47. View abstract
  155. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors. Biol Blood Marrow Transplant. 1997 Apr; 3(1):11-7. View abstract
  156. The changing role of radiation therapy in Neuroblastoma. Seminars in Radiation Oncology. 1997; 7:195-203. View abstract
  157. Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome. Blood. 1996 May 01; 87(9):3625-32. View abstract
  158. Radiotherapeutic Aspects of Hodgkin's Disease. Neoplastic Diseases of the Blood. 1996. View abstract
  159. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease. Cancer J Sci Am. 1995 May-Jun; 1(1):33-42. View abstract
  160. Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma. Ann Surg. 1995 Feb; 221(2):185-95. View abstract
  161. Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy. J Clin Oncol. 1994 Dec; 12(12):2567-72. View abstract
  162. Prognostic factors for patients with Hodgkin disease in first relapse. Cancer. 1993 Apr 15; 71(8):2613-20. View abstract
  163. Mobilization of hematopoietic stem and progenitor cell subpopulations from the marrow to the blood of mice following cyclophosphamide and/or granulocyte colony-stimulating factor. Blood. 1993 Apr 01; 81(7):1960-7. View abstract
  164. Monoclonal antibody-purged bone marrow transplantation therapy for multiple myeloma. Blood. 1993; 82:2568-2576. View abstract
  165. Autologous and Allogeneic Bone Marrow Transplantation for Poor Prognosis Patients with B-Cell Chronic Lymphocytic Leukemia. Blood. 1993; 82:1366-1376. View abstract
  166. Treatment of Hodgkin's Disease in patients with bulky mediastinal nodes in the upright mantle position. Int. J. Radiat. Oncol. Biol. Phys.,. 1992; 23:443-447. View abstract
  167. Deficient hemapoietic support capacity following transplantation of murine peripheral blood stem cells. Presented at the International Society of Hematology/American Society of Hematology. 1990. View abstract
  168. Human T-lymphotropic virus type III (HTLV-III). Hematol Pathol. 1987; 1(1):1-13. View abstract
  169. HTLV-III expression in infected lymph nodes and relevance to pathogenesis of lymphadenopathy. Am J Pathol. 1986 Dec; 125(3):436-42. View abstract
  170. Detection of HTLV-III RNA in lungs of patients with AIDS and pulmonary involvement. JAMA. 1986 Nov 07; 256(17):2356-9. View abstract
  171. Concomitant infection with HTLV-I and HTLV-III in a patient with T8 lymphoproliferative disease. N Engl J Med. 1986 Oct 23; 315(17):1073-8. View abstract
  172. Narcotic withdrawal syndrome in young adults after the therapeutic use of opiates. Am J Dis Child. 1986 Jun; 140(6):603-4. View abstract
  173. Familial pineoblastoma. Report of two cases. J Neurosurg. 1985 Jun; 62(6):930-2. View abstract